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Abstract: Acute lung injury is a clinical symptom that can cause morbidity, acute respiratory failure, and risk of developing pneumonia.
Mast cells are found more commonly in places where antigens can enter the body, such as skin and respiratory and digestive systems,
which enables them to be among the first groups of cell to act in the defense mechanism against foreign matter entry. Resveratrol is an
active substance which is found in the structure of many plants and which can be used against pathogens due to its antimicrobial effect.
The aim of our study is to show the degranulation and heterogeneity of mast cells and the presence of tryptase and chymase secreted
from their granules immunohistochemically in acute lung injury which occurs after blunt trauma and to research what kind of an effect
resveratrol has on mast cells in this process. Twenty adult female Sprague–Dawley rats were used in the study. The rats were randomly
assigned to four groups. The first group was the control group, the second was the contusion group, the third was resveratrol group, and
the fourth was the treatment group in which contusion was induced following 30 mg/kg intraperitoneal resveratrol administration. In the
present study, acute lung injury was created with trauma and the effects of resveratrol in this process on the distribution, heterogeneity,
degranulation, and immunohistochemical characteristics of mast cells were examined. It was concluded that resveratrol, which caused a
significant decrease in mast cell degranulation and increase in number following trauma, had an influential role in this process.
Key words: Blunt chest trauma, rat modeling of lung injury, mast cell, resveratrol, tryptase, chymase

1. Introduction
Acute lung injury is a clinical symptom that can cause
morbidity, acute respiratory failure [1,2], and risk of
developing pneumonia [3]. It generally develops as a result
of blunt thoracic trauma that occurs in traffic accidents
[4,5]. Besides causing local and systemic changes that may
result in septic complications, lung contusion can also
influence inflammatory response that occurs as a result
of injury [6]. Following trauma, neutrophil increase in
intraalveolar areas and deterioration in alveolar capillary
circulation and lung parenchymal tissue integrity can
develop [7]. It has been reported that susceptibility to
infections increases as a result of changes in natural
and adaptive immune system due to trauma [8] and
a significant increase is observed in the expression of
inflammatory mediators such as IL-6 and TNF [7].
Mast cells are found more commonly in places where
antigens can enter the body such as skin and respiratory and
digestive systems [9], which enables them to be among the
first groups of cell to act in the defense mechanism against
foreign matter entry [10]. In addition to functioning as

cells presenting antigens by processing antigens [11], they
are also reported to play a significant role in wound healing
[12] and developing immune response against sepsis
[13]. Secretory granules of various sizes in the cytoplasm
of mast cells [14] include primary mediators, such as
stored histamine, tryptase, and chymase, and secondary
mediators which are synthesized after stimulation, such
as IL-6 and TNF-α [15]. When these cells are stimulated
by immunological factors such as cytokines and physical
factors such as trauma and sunshine, they can be activated
by discharging granule content [14]. Mast cells, which
have effects in inflammatory and allergic reactions,
are common in lung tissue [16] and they play a role in
maintaining homeostasis of respiratory function [17].
Studies conducted have shown an association between the
severity of acute lung injury and mast cell density [18,19].
Resveratrol is an active substance which is found
in the structure of many plants and which can be used
against pathogens due to its antimicrobial effect [20].
Resveratrol, which is a polyphenolic antioxidant, has
an antiinflammatory effect [21]. It is reported to have
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antioxidant [22], cancer preventing, and blood sugar
lowering effects [23]. Studies conducted have shown
that resveratrol has an inflammation suppressing feature
in many phases of the inflammatory process [24],
antihistaminic effect in the lungs in allergic asthma [25],
and a decreasing effect on sepsis which develops during
acute lung injury [26].
The most common type of damage in rib cage blunt
trauma is lung contusion and acute pulmonary injury
occurs as a result of it. Drug therapy can be applied for
systemic septic complications which develop as a result
of trauma and inflammatory response, in order not to
affect the whole body and to minimize tissue damage.
At this stage, resveratrol is a commonly preferred active
substance used in suppressing inflammatory reactions.
Studies conducted have reported the presence of mast cells
following trauma and during healing process. Although
there are studies showing the association between
resveratrol and mast cells in acute lung injury, the number
of studies investigating their immunohistochemical
characteristics and heterogeneity is limited. The aim of
our study is to show the degranulation and heterogeneity
of mast cells and the presence of tryptase and chymase
secreted from their granules immunohistochemically in
acute lung injury which occurs after blunt trauma and to
research what kind of an effect resveratrol has on mast
cells in this process.
2. Materials and methods
The experimental protocol and all animal procedures
were approved by the Experimental Ethics Committee
(Experimental protocol number No: 23.07.2014/17).
Twenty female adult Sprague–Dawley rats with an
average weight of 250–300 g were used in the study. The
rats were randomly assigned to four groups. The first group
was the control group in which no intervention was made.
The second group was the contusion (trauma) group in
which chest contusion was induced. The third group was
resveratrol group, which was given 30 mg/kg resveratrol
intraperitoneally (i.p.). The fourth group was the treatment
group in which contusion was induced following 30 mg/kg
i.p. resveratrol administration. All the groups except the
first group were given intraperitoneal injection of ketamine
hydrochloride (100 mg/kg) and xylazine (10 mg/kg)
anesthesia, and chest trauma was induced with the help of
a standard mechanism. Rats were fixed on a platform with
their chests looking up and thoracic trauma was induced
with a free fall of a 0.3-kg aluminium weight which would
strike an average of 2.2 J energy in an aluminium pipe [27].
The rats in all groups were sacrificed after 24-h follow-up
and their lung tissues were taken. The lungs of the rats
were fixed in 10% formaldehyde solution for histological
examination. Following this, they were blocked in paraffin
after undergoing routine tissue tracking procedures.

2.1. Mast cell histochemical staining
In order to examine the normal histological structure of
the tissues, 5-µm sections taken from paraffin blocks were
stained with Crosmon trichrome staining technique [28].
Ten series of 5-μm thick sections taken from the blocks
at 30-μm intervals with 5% Toluidin Blue dye solution
prepared in citric acid disodium buffer were stained to
determine the mast cells [29]. In order to determine
subtypes of mast cells, 5-μm thick sections with 30-μm
intervals were taken from each block on the same lame
and stained with Alcian Blue (AB)/Safranin O (SO) (AB/
SO) combined staining method [29].
In the serial sections prepared to find out the numerical
distribution of mast cells, cell counts were performed with
a 100 square ocular micrometer (eyepiece graticule). The
mast cells at 100 square units of the ocular micrometer
were counted with a magnification of ×40. Cell count was
performed at 10 randomly chosen different areas of the
sections taken from lungs and the arithmetic mean of the
results was taken. All the data obtained by calculating the
square of 100 square ocular micrometer for ×40 objective
magnification with the help of micrometric lame were
turned into mast cell number within a unit area of 1 mm2
[30]. SPSS program was used in the comparison of mast
cell counts between groups and one-way ANOVA was
conducted [31]. The results were assessed with a minimum
5% error margin.
2.2. Immunohistochemical staining
Five-micrometer lung sections taken from paraffin blocks
were stained immunohistochemically by using mouse
monoclonal tryptase (Abcam, ab2378, England) and rabbit
polyclonal chymase (Biorbyt, orb11030, England) primary
antibodies with Streptavidin biotin complex method [32].
Histostain Plus (Zymed kit: 85-6743, United States) kit
was used as secondary antibody. After deparaffinization,
sections were heated in a microwave oven of 700 W within
citrate buffer (pH:6) solution for proteolysis. In order to
block endogenous peroxidase activity, the tissues were
incubated in 3% hydrogen peroxide solution. Following
washing with phosphate buffer solution (PBS), serum in
the kit was instilled to prevent nonspecific protein binding
in sections. 1/100 dilution of primary antibody was applied
to sections and they were stored at +4 °C for one night.
Only PBS solution was instilled on negative control group
tissues. Following the washing procedure, biotinylated
secondary antibody was instilled into sections and
incubated at streptavidin-HRP complex after washing. As
the last stage, 3,3’-diaminobenzidine (DAP) (The Thermo
Scientific, United States) was used as chromogen and the
slides were covered with entellan after counterstaining was
performed with hematoxylin.
In preparations which were stained histochemically
and immunohistochemically, chymase-positive and
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tryptase-positive mast cell distribution was evaluated
semiquantitatively. Semiquantitative assessment was made
as no positive cells in the scanned area (-), 1–2 cells (±),
3–4 cells (+),5–6 cells (++), 7 and more cells (+++) [33].
2.3. Statistical evaluation of data
In this study, variance analysis was performed for analysis
of differences between the averages of mast cell count in
trial groups, and Duncan multiple comparison tests were
conducted for analysis of differences between groups [30].
3. Results
3.1. Histological results
Mast cells stained metamacromasically with toluidin blue
in lung tissues of the control and experimental groups
were distinguished significantly. In alcian blue/safranin O
combined staining conducted to find out the subtypes of
mast cells, blue AB (+), red SO (+), and red-blue AB/SO
(+) (mixed) mast cells were observed in all groups in the
lung tissue (Figures 1 and 2).
Mast cells were observed to be located around sacculus
alveolaris, in interalveolar septal connective tissue and
around capillaries. Mast cells were found to be scattered in
visceral pleura of the lung, bronchial wall, and connective
tissue in the wall of terminal and respiratory bronchioles.
In addition, mast cells were found among smooth muscles.
No difference was found between groups in terms of mast

cell localization. Differences were found in numbers and
degranulation depending on the application. Mast cells and
degranulation were found to be in small numbers in the
control group (Figure 2a). A significant increase was found
in mast cell number and degranulation in the contusion
(trauma) group (Figure 2b). When the resveratrol group
was assessed, while increase was found in the cell number
and degranulation when compared with the control group,
a decrease was found when compared with the treatment
group. In the treatment group, a decrease was found in
mast cell number and especially in degranulation when
compared with the contusion group (Figures 1and 2).
When the groups were evaluated within themselves,
the highest increase in mast cell number and degranulation
was found in the contusion group. In the treatment group,
a significant decrease was found when compared with
the contusion group. The suppressive role of resveratrol
on the mast cell count and degranulation in contusion of
lung tissue was found to be a significant result of our study
(Figure 3, Table 1).
3.2. Immunohistochemical results
The immunohistochemically found localizations of
chymase- and tryptase-positive mast cells in lung tissue are
in parallel with the results we obtained with histochemical
stain. The lowest number of mast cells was found in the
control group, while the highest number of mast cells was

Figure 1. Lung tissues were stained by Alcian blue Safranin O. Control group (a), trauma group
(b), resveratrol group (c), and resveratrol+trauma (treatment) group (d). Arrow: mast cells;
thick arrow: mast cells of mixed type ×40.
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Figure 2. Lung tissues were stained by Toluidine blue. Control group (a), trauma group (b),
resveratrol group (c), and resveratrol+trauma (treatment) group (d). Arrow: mast cells, ×40.

Figure 3. Statistical evaluation of mast cells.

found in the trauma group. Chymase-positive mast cells
were found to show a higher increase in number in the
trauma group when compared with tryptase-positive cells.
Chymase- and tryptase-positive mast cells were found to
be less in number in the treatment group when compared
with the trauma group. It was found that resveratrol caused
decrease in posttrauma chymase- and tryptase-positive
mast cell degranulation and number of cells. (Figures 4
and 5, Table 2).

4. Discussion
It has been found that complications can develop after
lung contusion and that it can affect inflammatory
response with local and systemic changes [6]. It is known
that the immune system is stimulated due to trauma
[8]. It is reported that mast cells, which are commonly
found in lung tissue [16], discharge their granule content
when they are stimulated by trauma and immunological
content [14] and play a significant role in inflammatory
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Table 1. Mast cell counts after staining with toluidin blue in lung tissue.
Group

Mast cell count
(× ±Sx /mm2)

Minimum

Maximum

Contol

17.28±0.93a

14.40

19.20

Trauma (contusion)

c

27.52±0.93

25.60

30.40

Resveratrol

20.80±0.71b

19.20

22.40

Resveratrol + Trauma (Treatment)

22.72±1.17

19.20

25.60

P

***

b

a, b, c: Means with different letters in the column differ significantly
(P < 0.5)
***: P < 0.001

Figure 4. Lung tissues obtained from different treatment groups were immunostained with
antibodies against chymase. Control group (a), trauma group (b), resveratrol group (c) and
resveratrol+trauma group (d). Arrow: mast cells, ×40.

and allergic reactions [16], wound healing [12], and
developing immune response against sepsis [13]. Studies
conducted have reported resveratrol to have suppressive
characteristics in many stages of the inflammation process
[24] and a decreasing influence on sepsis which develops
in acute lung injury [26].
Vander et al. reported in their study that the number
of chymase-positive mast cells increased in lungs with
chronic asthma [34]. Similarly, in another study, it was
reported that the number of chymase-positive mast cells
in lungs with interstitial pneumonia increased compared
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to the control group [35]. The significant increase in
chymase-positive mast cell numbers in the trauma group
in our study is consistent with other studies. In addition,
an increase in the number of chymase-positive mast cells
was reported in many studies in which viral infections
in the lungs, asthma, chronic obstructive pulmonary
syndrome, pulmonary hypertension, and lung fibrosis
were established, similar to our study [36–39].
Tryptase released from mast cells is known to be a potent
growth factor for epithelial cells, airway smooth muscle
cells, and fibroblasts. [40]. In many studies conducted
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Figure 5. Lung tissues obtained from different treatment groups were immunostained with antibodies against
tryptase. Control group (a), trauma group (b), resveratrol group (c), and resveratrol+trauma group (d). Arrow:
mast cells, ×40.
Table 2. Tryptase- and chymase-positive cell reaction in lung tissue of different groups.
Control

Trauma
(contusion)

Resveratrol

Resveratrol +
trauma (treatment)

Tryptase

±

++

+

++

Chymase

±

+++

+

+

No positive cell (-), 1-2 cells (±), 3-4 cells (+), 5-6 cells (++), 7 and more cells (+++)

with the lungs, it has been shown that tryptase-positive
mast cells are found in the connective tissue around the
capillaries [35], between the smooth muscles surrounding
the bronchi [41], in the lung parenchyma tissue [42], and
in the wall of the alveoli [43]. The findings of our study
are similar to the studies in the literature. Gossman et al.
reported that there is degranulation in tryptase-positive
mast cells in lungs with chronic obstructions [44].
Increases in the number of tryptase-positive mast cells
have also been reported in diseases such as acute lung
injury, sepsis, pneumonia, and allergic respiratory tract
[35,41–43,45,46]. In a different study, it was reported that
tryptase-positive mast cell increase was formed in the

cortical region of the brain in rats with head trauma [47].
In our study, tryptase-positive mast cell increase in trauma
and resveratrol groups is in parallel with other studies in
the literature [35, 41–43,45–47]
There are studies which have similar results to the
ones we found in our study with Alcian blue/safranin O
combined staining. In their study, Wilkes et al. [48] showed
the presence of red-stained SO(+) and blue-stained AB(+)
mast cells. In their study, Tomita et al. [49] reported a
numerical increase in safranin-positive mast cells in rat
lungs in helminth infection.
In studies conducted on acute lung injury in rat lungs
[50], anaphylactic mouse skin [51], and humans [52],
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resveratrol has been reported to show a decreasing effect
on mast cell degranulation. Some studies have reported
that while an increase was found in mast cell number in
rats with allergic rhinitis [53], fibrosis prostate [54], and
urinary bladder with fibrosis, there was a decrease in
numerical increase in groups administered resveratrol.
The most striking results of our study, i.e. the decrease
in the increase in mast cell degranulation and mast cell
numbers, are in parallel with those of other studies.
Mast cells in lung tissue have been found to increase in
number in rats exposed to hyperoxia [55] and in mice with
sistosoma infestation [56]. Mast cells which increase in
acute lung injury have been found to decrease when given
montelukast used in asthma treatment [57]. Degranulation
has been reported in lung fibrosis [58] and in rats in which
experimental migraine head ache was induced [59]. It has
been found that less degranulation developed in groups
administered herbal medical therapy when compared with
rats in which chronic obstructive lung disease developed
with cigarette smoke [60]. Our results that the number of
mast cells increased due to trauma and complications and
that this increase was suppressed with resveratrol are in

parallel with those of the aforementioned studies [55–60].
Acute lung injury is a symptom which can result in death
if not treated immediately and which can cause pneumonia
and a systemic disorder that can influence the whole body,
mostly in respiratory failure that develops as a result of
chest traumas. Mast cells, which are known to have a role
in the homeostasis of respiratory functions, contribute
to defense and wound healing process. Resveratrol,
an antioxidant, is known to be used in inflammatory
reactions. In the present study, acute lung injury was
created with trauma and the effects of resveratrol in this
process on the distribution, heterogeneity, degranulation,
and immunohistochemical characteristics of mast cells
were examined. It was concluded that resveratrol, which
caused a significant decrease in mast cell degranulation
and increase in number following trauma, had an
influential role in this process. As a conclusion, we believe
that our results will contribute to the association between
resveratrol, trauma, and mast cells; and that physiological,
biochemical, and different immunohistochemical studies
to be conducted will clarify the mast cell function in
trauma and inflammatory response in more detail.
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